Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0923-2023

Drug recall · July 26, 2023

Tizanidine Tablets USP recall

Why: Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10

Lots / codes

Lot: T2100585, T2100586, T2100587, Exp 12/2023

Quantity
17,548 1000-countbottles
Company
Dr Reddy's Laboratories Limited, Ranasthalam Mandal, Srikakulam, N/A
Distribution
Nationwide in the USA
Initiated
June 21, 2023 · N/A
Classified
July 17, 2023
Reported
July 26, 2023
How notified
N/A

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Tizanidine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.